Ctim-18. Luminos-101: Initial Safety and Tolerability of Pvsripo and Pembrolizumab Combination Therapy in Recurrent Glioblastoma
Year: 2021
Type: article
Source: Neuro-Oncology
Authors: Andrew Sloan, Robin Buerki, Daniel Landi, Annick Desjardins, Allan Friedman, Prakash Ambady, Kevin Becker, Nicholas Butowski, Robert Cavaliere, William Curry, Shirley Ong, Rafael Vega, Patrick Wen, Bruno Bockorny, E Antonio Chiocca, J Bradley Elder, Ketan Bulsara, Mitchel Berger, Elizabeth Gerstner, Eric Sauvageau, Andrea Kelly, Lori Mixson, LeAnn Jackson, Chris Learn, Adam Dickinson, W Garrett Nichols
Institutions: University Hospitals Cleveland Medical Center, University Hospitals Seidman Cancer Center, Duke University, Duke University Health System, Oregon Health & Science University, UConn Health, University of California, San Francisco, Baptist MD Anderson Cancer Center, Massachusetts General Hospital, The Ohio State University Wexner Medical Center, Beth Israel Deaconess Medical Center, Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard University
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3215375734